80 likes | 99 Views
Hemoglobin A1c testing devices market is driven factors such as high prevalence and increase in the incidence of diabetes, rise in the geriatric population, increase in employer-sponsored medical programs, improvements in health care facilities, and rise in medical tourism.
E N D
Hemoglobin A1c Testing Devices Market By Technology - Ion-exchange High-performance Liquid Chromatography (HPLC), Immunoassay, BoronateAffinity Chromatography, Direct Enzymatic Assay; End user - Laboratory Testing (Commercial Laboratory and Others), Point-of-care (POC) Settings (Hospitals, Home Care, Clinics and Forecast 2018 - 2026 ©2019 Transparency Market Research, All Rights Reserved
Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Acronyms Used Chapter 3 Research Methodology Chapter 4 Executive Summary Chapter 5 Market Overview Chapter 6 Global Hemoglobin A1c Testing Devices Market Analysis, by Technology Chapter 7 Global Hemoglobin A1c Testing Devices Market Analysis, by End-user Chapter 8 Global Hemoglobin A1c Testing Devices Market Analysis and Forecasts, by Region Chapter 9 North America Hemoglobin A1c Testing Devices Market Analysis Chapter 10 Europe Hemoglobin A1c Testing Devices Market Analysis Chapter 11 Asia Pacific Hemoglobin A1c Testing Devices Market Analysis Chapter 12 Rest of the World Hemoglobin A1c Testing Devices Market Analysis Competition Landscape ©2019 Transparency Market Research, All Rights Reserved Chapter 13
Reports Highlights • Global Hemoglobin A1c Testing Devices Market to Reach US$ 4,074.6 Mn by 2026 and is projected to expand at a CAGR of ~10.4% from 2018 to 2026. • Hemoglobin A1c testing devices are used to determine and monitor hemoglobin A1c levels in diabetic patients. • The A1c test measures the average blood glucose over the past two to three months. It is also known as the glycosylated hemoglobin test, glycohemoglobin test, glycated hemoglobin test, or A1c. • Owing to factors such as high prevalence and increase in the incidence of diabetes, rise in the geriatric population, increase in employer-sponsored medical programs, improvements in health care facilities, and rise in medical tourism. ©2019 Transparency Market Research, All Rights Reserved
Continue.. In terms of technology, the Hemoglobin A1c Testing Devices Market has been segmented into ion-exchange high-performance liquid chromatography, immunoassay, boronate affinity chromatography, direct enzymatic assay, and others. • Based on end-user, the market has been classified into laboratories and point-of-care (POC) settings. The laboratories segment has been further sub-segmented into commercial laboratories and others. • In terms of region, the market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. North America and Europe • Key players operating in the global hemoglobin A1c testing devices market include : Siemens, Healthineers, Abbott Laboratories, Arkray, Inc., Bio-Rad Laboratories, Inc., Polymer Technology Systems, Inc., Danaher Corporation (Beckman Coulter), EKF Diagnostics Holdings plc, F. Hoffmann- La Roche Ltd., Menarini Group, Sebia, Tosoh Corporation, and Trinity Biotech plc. • Request Sample of Report ©2019 Transparency Market Research, All Rights Reserved
Contact Us Mr. Rohit Bhisey Transparency Market Research State Tower, 90 State Street, Suite 700, Albany, NY – 12207, United States Tel: +1-518-618-1030, USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com Research Blog: https://www.europlat.org/ ©2019 Transparency Market Research, All Rights Reserved